{"id":39286,"date":"2017-05-26T06:45:57","date_gmt":"2017-05-26T10:45:57","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39286"},"modified":"2017-05-26T04:56:33","modified_gmt":"2017-05-26T08:56:33","slug":"repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286","title":{"rendered":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Repros Therapeutics Inc (NASDAQ:RPRX), <\/strong>which happens to be one of the industry leaders has today come forward to make an announcement regarding its entry into an underwriting agreement in which it is believed to be seeking to sell about 2,744,125 shares of the Company\u2019s common stock in a public offering.<\/p>\n<p style=\"text-align: justify;\">In this particular light it is also crucial to point out the pre-funded Series C warrants\u00a0which are as a matter of fact set to help towards the purchase of about 2,245,875 shares of Common Stock, which according to a number of reliable sources will be offered in lieu of Common Stock to those purchasers whose purchase of Common Stock in the offering would otherwise culminate in the respective purchaser beneficially owning quite some large proportion of the providers common stock. Of course this follows the completion of the most recent offering.<\/p>\n<p style=\"text-align: justify;\">The company\u2019s insiders have brought about a number of interesting revelations. The top provider intends to use the proceeds from the offering to fund the various general corporate undertakings. In the same light it has also been revealed that the offering will eventually be closing on or about May 23, 2017, and that will of course be subject to the satisfaction of a number of the customary closing conditions.<\/p>\n<p style=\"text-align: justify;\">The different businesses worldwide are facing up to the reality of the business dynamics; technological advancements topping the list. One thing that anyone will as a matter of fact agree to is that the top provider undertook a prudent move by going ahead and channel its funds it the corporate developments.<\/p>\n<p style=\"text-align: justify;\">With the wild competition being experienced in the world markets, it is important for any business to lay down working strategies to help it survive in the competitive world and proper allocation of resources cannot by any means be underrated.<\/p>\n<p style=\"text-align: justify;\">While addressing a press conference, one of the company\u2019s top executive outlined that the company was getting more serious with its recruitment of members to work in the various positions. He proceeded to add that they hoped for the very best in the nearby future where they will be able to climb higher in terms of business success.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Repros Therapeutics Inc (NASDAQ:RPRX), which happens to be one of the industry leaders has today come forward to make an announcement regarding its entry into [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":39293,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12667,12666,12665],"stock_ticker":[],"class_list":["post-39286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqrprx","tag-repros-therapeutics-inc","tag-repros-therapeutics-inc-nasdaqrprx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Repros Therapeutics Inc (NASDAQ:RPRX), which happens to be one of the industry leaders has today come forward to make an announcement regarding its entry into [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-26T10:45:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock\",\"datePublished\":\"2017-05-26T10:45:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\"},\"wordCount\":381,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg\",\"keywords\":[\"NASDAQ:RPRX\",\"Repros Therapeutics Inc\",\"Repros Therapeutics Inc (NASDAQ:RPRX)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\",\"name\":\"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg\",\"datePublished\":\"2017-05-26T10:45:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg\",\"width\":1600,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286","og_locale":"en_US","og_type":"article","og_title":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR","og_description":"Repros Therapeutics Inc (NASDAQ:RPRX), which happens to be one of the industry leaders has today come forward to make an announcement regarding its entry into [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-05-26T10:45:57+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock","datePublished":"2017-05-26T10:45:57+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286"},"wordCount":381,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg","keywords":["NASDAQ:RPRX","Repros Therapeutics Inc","Repros Therapeutics Inc (NASDAQ:RPRX)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286","url":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286","name":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg","datePublished":"2017-05-26T10:45:57+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39292-R3dpQ0l.jpg","width":1600,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/repros-therapeutics-inc-nasdaqrprx-announces-warrants-to-purchase-common-stock-and-the-pricing-of-3-0-million-public-offering-of-common-stock-39286#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Repros Therapeutics Inc (NASDAQ:RPRX) Announces Warrants To Purchase Common Stock And The Pricing Of $3.0 Million Public Offering Of Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39286"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39293"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39286"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}